Company intelligence / Profile preview

Sorin Capital Management

Milan, Italy

Ownership: Private
Employees: ~3900
Development stage: Other

Overview

Sorin Group was a leading global medical technology company specializing in the treatment of cardiovascular diseases. Headquartered in Milan, Italy, the company was a world leader in cardiac surgery and a significant player in cardiac rhythm management and heart valve repair. In 2015, Sorin Group merged with Cyberonics to form LivaNova, a premier global medical technology company. The company's legacy includes innovative products such as the Perceval sutureless heart valve, the Inspire oxygenator, and the Kora pacing system, which continue to be utilized in clinical settings worldwide.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

MicroPort Scientific

Beyond the preview

Go deeper on Sorin Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorin Capital Management.

Explore the full profile